Home Details
| Official Symbol of Gene | USP18 |
| Species | Homo sapiens |
| Entrez Gene ID | 11274 |
| Official Full Name | ubiquitin specific peptidase 18 |
| Also known as | ISG43; UBP43; PTORCH2 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000184979 MIM:607057; AllianceGenome:HGNC:12616 |
| Map Location | 22q11.21 |
| Detected Sample | PBMCs |
| Sample Detail | N/A |
| Detected Method | RT-PCR |
| Disease | MS |
| Disease subtype | RRMS |
| Population | N/A |
| Sample Size | 14 RRMS patients / 15 healthy controls |
| Pubmed ID | 21886806 |
| Year | 2011 |
| Title | Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis |
| Expression | down-regulation |
| Risk type | Disease risk |
| Result | Expression levels for this gene were significantly lower in MS patients compared with controls. |
| Mechanism/Pathway | USP18 codes for a type I IFN-inducible cysteine protease that deconjugates ISG15, a ubiquitin-like protein, from target proteins.Interestingly, USP18 has been shown to negatively regulate the type I IFN signalling pathway, and its deficiency results in enhanced and prolonged STAT1 phosphorylation.This action appears to be independent of its protease activity and mediated by the specific binding of USP18 to IFNAR2, which then blocks the interaction between JAK1 and the IFN receptor and results in inhibition of the downstream phosphorylation cascade.Although further studies are needed, it is tempting to speculate that a deficient expression of USP18 in MS patients may lead to overactivation of the type I IFN pathway and have implications in the therapeutic response to IFNβ. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.